// App-Quantinova.ai

FRI-172 : RAD1901 a Novel Estrogen Receptor Ligand with a Unique Pharmacologic Profile for Potential Use in the Treatment of Postmenopausal Vasomotor Symptoms

Researchers

Presenter

  • Alan G Harris

Principal Investigators

  • Ginger D Constantine

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Radius Health, Inc.

  • EndoRheum Consultant

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Breast cancer

  • Osteoporosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bazedoxifene acetate

  • Ospemifene

  • Raloxifene

  • Alora

  • Estrogens

  • Tamoxifen

  • RAD 1901

Outcome

  • N/A

Study Design

  • randomized

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved